OSI Pharma (OSIP) Downgraded at Lazard Following Tarceva News
Tweet Send to a Friend
Shares of OSI Pharma (Nasdaq: OSIP) have tumbled more than 3% today following news last night after the close that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


